Top compounds associated with response to TECRL


Feature Type Standardized
Nominal ANOVA
mRNA selumetinib:navitoclax (8:1 mol/mol) CTRPv2 pan-cancer AAC 0.00016 1
mRNA PD318088 CTRPv2 pan-cancer AAC -5.5e-05 1
mRNA AZD0530 CTRPv2 pan-cancer AAC -3.5e-05 1
mRNA PI-103 CTRPv2 pan-cancer AAC 1.8e-05 1
Download CSV